# Alnylam Pharmaceuticals, Inc.: Form 8-K, filed Oct 31, 2024

- Company: [Alnylam Pharmaceuticals, Inc.](/companies/alny.md) (CIK 1178670)
- Form: 8-K
- Filed: 2024-10-31
- Accepted by EDGAR: Oct 31, 2024, 08:10 ET
- Period: 2024-10-31
- Accession: 0001178670-24-000052
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1178670/000117867024000052/alny-20241031.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1178670/000117867024000052/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1178670/000117867024000052/alny-20241031.htm

Filed Oct 31, 2024.
Source: SEC EDGAR, the filing index for accession 0001178670-24-000052. Last ingested by Listed: Nov 14, 2026, 23:27 ET. No prices; not investment advice.
